Data Category | Data Item (N = 62) | Visit |
---|---|---|
Demographic data | 1.1 NHS number of patient | All |
1.2 Date of attendance / visit date | All | |
2.1 Gender | First | |
2.2 Date of birth | First | |
2.3 Ethnicity | First | |
Clinical history data (diagnosis and disease features) | 6.1 Date of symptom onset | First |
6.2 ILAR sub-type | First/Clinically indicated | |
6.3 Date of diagnosis | First/Clinically indicated | |
6.4 Relevant co-morbidities | First/Clinically indicated | |
6.5 Morning stiffness of joints | All | |
6.7.A Systemic features | First/Clinically indicated | |
6.7.B Systemic JIA Global Assessment | First/Clinically indicated | |
6.8.A Uveitis history | All | |
6.8.B Uveitis status at most recent eye examination | All | |
Medication data | 7.1 Medication name | All |
7.2.A Date of decision to treat or change treatment | All | |
7.2.B Date treatment started / date of single treatment | All | |
7.3 Dose | All | |
7.4 Frequency | All | |
7.5 Route | All | |
7.6 Date medication stopped or changed | All | |
7.7 Reason for stopping or changing medication | All | |
7.8 Joints injected with intra-articular steroids | All | |
7.9 Adverse drug reactions | All | |
Examination data | 3.1 Height | All |
3.2 Weight | All | |
6.6 Leg length discrepancy | First/Clinically indicated | |
COV / patient reported data | 4.1.A Active joint assessment | All |
4.1.B Swollen joint assessment | All | |
4.1.C Tender joint assessment | All | |
4.2 Limited joint assessment | All | |
4.3 Physician Global Assessment | All | |
4.4 Patient / Parent Global Assessment of overall well-being | All | |
4.5.A CHAQ / HAQ (final numeric score) | All | |
4.5.B CHAQ multiple choice questions | All | |
4.5.C CHAQ yes/no questions | All | |
8.10 Date form completed (CHAQ/PREM/PROM) | All | |
8.11 Form type (patient or parent) (CHAQ/PREM/PROM) | All | |
8.12 Completed by (CHAQ/PREM/PROM) | All | |
8.13 Time taken to complete form (CHAQ/PREM/PROM) | All | |
8.14 JIA-specific patient reported experience measure (PREM) | All | |
8.15 JIA-specific patient reported outcome measure (PROM) | All | |
Once only lab data | 5.1 RF +/− | First/Clinically indicated |
5.2 HLA B27 +/− | Once if indicated | |
5.3 ANA +/− | First/Clinically indicated | |
Structure of the care team | ||
Quality of care data | 8.1 Date of referral letter being received in rheumatology department | First |
8.2.A Date of first appointment offered in a rheumatology clinic | First | |
8.2.B Date of first appointment in a rheumatology clinic | ||
8.3 Does steroid injection specify a dedicated Paediatric GA list? | All | |
8.4 Date of first eye screen | All | |
8.5 Date patient was counselled before starting methotrexate | All | |
8.6 Date patient was counselled before starting a biologic | All | |
8.7 Clinic type / organisation | All | |
8.8.A Is patient eligible for recruitment to BSPAR Etanercept Study? | All | |
8.8.B Has patient been recruited to the BSPAR Etanercept Study? | All | |
8.9.A Is the patient eligible for recruitment to the BCRD study? | All | |
8.9.B Has the patient been recruited to the BCRD study? | All |